Cyril Amarchand Mangaldas (“CAM“) advised Serum Institute on the proposed sale of stake in Biocon Biologics to Biocon and subscription of shares in Biocon through a share swap, valued at INR 2250 Crore.
The transaction team advising Serum was led by Anchal Dhir, Partner, with assistance from Varun Kannan, Senior Associate, Mahin Rai, Senior Associate and Animesh Pandey, Associate.
Avaantika Kakkar, Partner (Head – Competition) advised on competition law aspects of the transaction.